<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Neuropsychopharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Int. J. Neuropsychopharmacol</journal-id><journal-id journal-id-type="publisher-id">ijnp</journal-id><journal-title-group><journal-title>International Journal of Neuropsychopharmacology</journal-title></journal-title-group><issn pub-type="ppub">1461-1457</issn><issn pub-type="epub">1469-5111</issn><publisher><publisher-name>Oxford University Press</publisher-name><publisher-loc>US</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">5616911</article-id><article-id pub-id-type="doi">10.1093/ijnp/pyw044.577</article-id><article-id pub-id-type="publisher-id">pyw044.577</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstracts</subject><subj-group subj-group-type="category-toc-heading"><subject>Tuesday Abstracts</subject></subj-group></subj-group></article-categories><title-group><article-title>PT577. Distribution of Human Umbilical Cord Blood-derived Mesenchymal Stem Cells (hUCB-MSCs) in the Alzheimer&#x02019;s Disease Transgenic Mouse after a Single Intravenous Injection</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Park</surname><given-names>Sang Eon</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Na Kyung</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Jeongmin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hwang</surname><given-names>Jung Won</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Soo Jin</given-names></name><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Hwang</surname><given-names>Hyeri</given-names></name><xref ref-type="aff" rid="aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Hyung</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Chang</surname><given-names>Jong Wook</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Na</surname><given-names>Duk L.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>Samsung Advanced Institute for Health Science and Technology, Sungkyunkwan University, South Korea</aff><aff id="aff2">
<label>2</label>Department of Neurology, Samsung Medical Center, 50 Ilwon-dong, Gangnam-ku, Seoul 135&#x02013;710, South Korea</aff><aff id="aff3">
<label>3</label>Neuroscience Center, Samsung Medical Center, Seoul, Republic of Korea</aff><aff id="aff4">
<label>4</label>Stem Cell &#x00026; Regenerative Medicine Center, Research Institute for Future Medicine, Samsung Medical Center, 135&#x02013;710, Seoul, Republic of Korea</aff><aff id="aff5">
<label>5</label>Biomedical Research Institute, MEDIPOST Co., Ltd., 463-400, Gyeonggi-do, Republic of Korea</aff><aff id="aff6">
<label>6</label>King&#x02019;s College London, London, United Kingdom</aff><aff id="aff7">
<label>7</label>McGill University, 845 Sherbrooke Street West, Montreal, QC H3A OG4, Canada</aff><pub-date pub-type="collection"><month>6</month><year>2016</year></pub-date><pub-date pub-type="epub" iso-8601-date="2016-05-27"><day>27</day><month>5</month><year>2016</year></pub-date><volume>19</volume><issue>Suppl 1</issue><fpage seq="k">12</fpage><lpage>13</lpage><permissions><copyright-statement>&#x000a9; The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.</copyright-statement><copyright-year>2016</copyright-year></permissions><self-uri xlink:href="pyw044.577.pdf"/><counts><page-count count="2"/></counts></article-meta></front><body><p>
<bold>Abstract</bold>
</p><p>
<bold>Backgrounds</bold>: The aim of this study was to track the migration of human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) administered via a single intravenous injection and to observe the consequential therapeutic effects in a transgenic Alzheimer&#x02019;s disease (AD) mouse model.</p><p>
<bold>Methods</bold>: 10-month-old APP/PS1 mice received a total injection of 1&#x02009;&#x000d7;&#x02009;10^6 cells through the lateral tail vein and were sacrificed 1, 4, and 7 days after administration.</p><p>
<bold>Results</bold>: Based upon immunohistochemical analysis, hUCB-MSCs were not detected in the brain for each time point. Instead, most of the injected MSCs were found to be distributed in the lung, heart, and liver. In terms of the molecular effects, statistically significant differences in the amyloid beta protein, Neprilysin (NEP), and SOX2 levels were not observed among the groups.</p><p>
<bold>Conclusion</bold>: Our study showed that a single dose of 1X10^6 hUCB-MSCs injected intravenously into AD transgenic mice resulted in neither delivery into the brain nor generation of therapeutic benefits via paracrine activity. In order to utilize the intravenous route as an effective delivery route for AD stem cell therapy, it will be crucial to perform additional studies on how to increase the permeability of the BBB and how to decrease the entrapment of cells in organs such as the lung and liver.</p></body></article>